The structural profiles are close, with Ionis Pharmaceuticals carrying a narrow edge on growth. Tempus AI still has the edge on growth, which keeps the comparison from looking entirely one-sided. On the market side, Ionis Pharmaceuticals is in better shape — its trend is intact while Tempus AI's trend has broken down. That puts structure and market broadly in agreement — Ionis Pharmaceuticals's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.
The page question resolves through growth, where Tempus AI, Inc. holds the stronger read even though the broader score still favours Ionis Pharmaceuticals, Inc..
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
The pair shares a valid long-term profile match, but the trajectories are not especially close.
Most of the shared profile comes through revenue stability and capital structure.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
The setup is mixed: neither company clearly combines the stronger profile with the more supportive price setup.
Valuation position uses peer-relative valuation score where available.
The clearest distance comes from a stronger growth profile.
Tempus AI, Inc. still carries lower volatility exposure — that difference is real enough to prevent the comparison from becoming one-sided.
The lead is built on both growth and profitability — though growth still provides a counterweight.
Break down the IONS vs TEM comparison across all dimensions with the full interactive tool.
Explore how IONS and TEM each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.